Immunological Medicines for Pigs
Immunological veterinary medicinal products, including vaccines, are authorised for pigs.
Name
|
Description
|
Marketing Authorisation Holder
|
License Number
|
License Date
|
Animal
|
Further Information
|
Porcilis Parvo
|
Parvovirose
|
Intervet Deutschland GmbH
|
211a/94 |
04.11.1998 |
Schwein |
PharmNet.Bund
|
Porcilis PCV
|
Circovirus-Infektion
|
Intervet International B.V., Niederlande
|
EU/2/08/091/001-010 |
12.01.2009 |
Schwein |
EPAR: Porcilis PCV
|
Porcilis PCV ID
|
Circovirus-Infektion
|
Intervet International B.V., Niederlande
|
EU/2/15/187/001-004 |
28.08.2015 |
Schwein |
EPAR: Porcilis PCV ID
|
Porcilis PCV M Hyo
|
Circovirus-Infektion, Enzootische Pneumonie
|
Intervet International B.V., Niederlande
|
EU/2/14/175/001-010 |
07.11.2014 |
Schwein |
EPAR: Porcilis PCV M Hyo
|
Porcilis PCV M Hyo ID
|
Circovirus-Infektion, Enzootische Pneumonie
|
Intervet International B.V., Niederlande
|
EU/2/24/319 |
02.09.2024 |
Schwein |
EPAR: Porcilis PCV M Hyo ID
|
Porcilis Porcoli Diluvac Forte
|
E. coli-Ferkelenteritis
|
Intervet International BV, Niederlande
|
EU/2/96/001/003-008 |
22.05.2002 |
Schwein |
EPAR: Porcilis Porcoli Diluvac Forte
|
Porcilis PRRS
|
PRRS
|
Intervet Deutschland GmbH
|
PEI.V.01706.01.1 |
03.11.2000 |
Schwein |
PharmNet.Bund
|
Progressis
|
PRRS
|
Ceva Tiergesundheit GmbH
|
PEI.V.01709.01.1 |
28.11.2000 |
Schwein, Jungsau, Zuchtsau |
PharmNet.Bund
|
ReproCyc ParvoFLEX
|
Parvovirose
|
Boehringer Ingelheim Vetmedica GmbH
|
EU/2/19/237 |
26.04.2019 |
Schwein |
EPAR: ReproCyc ParvoFLEX
|
ReproCyc PRRS EU
|
PRRS
|
Boehringer Ingelheim Vetmedica GmbH
|
PEI.V.11723.01.1 |
24.03.2015 |
Schwein |
PharmNet.Bund
|
RESPIPORC Flu 3
|
Schweineinfluenza
|
CEVA Santé Animale
|
EU/2/09/103/001-006 |
14.01.2010 |
Schwein |
EPAR: Respiporc Flu 3
|
RESPIPORC FLUpan H1N1
|
Schweineinfluenza
|
CEVA Santé Animale
|
EU/2/17/209/001-002 |
17.05.2017 |
Schwein |
EPAR: Respiporc Flupan H1N1
|
Rhiniseng
|
Rhinitis atrophicans
|
Laboratorios Hipra, S.A., Spanien
|
EU/2/10/109/001-009 |
16.09.2010 |
Schwein |
EPAR: Rhiniseng
|
Rindertuberkulin - PPD
|
Tuberkulin zur Diagnose der Rindertuberkulose beim Rind und anderen Haussäugern
|
WdT - Wirtschaftsgenossenschaft Deutscher Tierärzte eG
|
458a/85 |
28.06.2007 |
Hund, Rind, Schaf, Schwein, Ziege |
PharmNet.Bund
|
SALMOPORC
|
Salmonellen-Infektion
|
Ceva Tiergesundheit GmbH
|
PEI.V.02340.01.1 |
25.07.2002 |
Schwein |
PharmNet.Bund
|
Stellamune Mykoplasma
|
Enzootische Pneumonie
|
Elanco GmbH
|
145a/93 |
19.06.1995 |
Schwein |
PharmNet.Bund
|
Stellamune One
|
Enzootische Pneumonie
|
Elanco GmbH
|
PEI.V.02633.01.1 |
05.06.2002 |
Schwein |
PharmNet.Bund
|
Suigen APP 2, 9, 11
|
Actinobazillus pleuropneumonie
|
VIRBAC, Frankreich
|
PEI.V.12153.01.1 |
12.06.2023 |
Schwein |
|
Suigen Entero 3
|
E. coli-Infektion, Rotavirus-Infektion, Clostridien-Infektion
|
Bioveta a.s., Tschechien
|
PEI.V.12174.01.1 |
29.04.2024 |
Schwein |
|
Suigen Rota Coli
|
E. coli-Infektion, Rotavirus-Infektion
|
Virbac S.A., Frankreich
|
PEI.V.12117.01.1 |
13.06.2021 |
Schwein |
|
Suiseng
|
E. coli-Enterotoxikose, Nekrotisierende Enteritis, Clostridien-Infektion
|
Laboratorios Hipra, S.A., Spanien
|
PEI.V.04349.01.1 |
07.09.2009 |
Schwein |
PharmNet.Bund
|
Suiseng Coli / C
|
E. coli-Infektion, Clostridien-Infektion
|
Laboratorios Hipra S.A., Spanien
|
PEI.V.12026.01.1 |
01.04.2020 |
Schwein |
PharmNet.Bund
|
Suiseng Diff/A
|
Clostridien-Infektion (Clostridioides difficile, Clostridium perfringens)
|
Laboratorios Hipra, S.A., Spanien
|
EU/2/21/278 |
07.12.2021 |
Schwein |
EPAR: Suiseng Diff/A
|
Suivac APP
|
Actinobacillus Pleuropneumonie
|
ChemVet DK A/S, Dänemark
|
PEI.V.11863.01.1 |
01.09.2016 |
Schwein |
PharmNet.Bund
|
Suvaxyn Circo
|
Circovirus-Infektion
|
Zoetis Belgium S.A., Belgien
|
EU/2/17/223/001-006 |
07.02.2018 |
Schwein |
EPAR: Suvaxyn Circo
|
Disclaimer
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 528 in BAnz AT 25.04.2025 B4.
Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.